相关实验视频

Updated: May 25, 2025

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

固体瘤中的CNPY2:机制,生物标志物潜力和治疗影响

Sayan Mullick Chowdhury¹, Feng Hong^1,2, Christian Rolfo¹

¹Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.

|February 26, 2025

概括

罩FGF信号调节器2 (CNPY2) 通过影响关键通路驱动固体瘤生长. 需要进一步的研究来探索 CNPY2 .

科学领域:

在瘤学瘤学.
分子生物学分子生物学
癌症研究癌症研究

背景情况:

顶FGF信号调节器2 (CNPY2) 与癌症发展有关.
CNPY2促进细胞增殖,组织修复和血管生成.

研究的目的:

审查CNPY2在固体瘤中的作用.
探索CNPY2对癌症途径和治疗潜力的影响.

主要方法:

对CNPY2在各种癌症中的功能进行文献综述.
对CNPY2对信号通路的调制进行分析 (p53,MYLIP,NF-κB,AKT/GSK3β).

主要成果:

在细胞癌,前列腺癌,肝细胞癌和非小细胞肺癌中,CNPY2不同影响瘤生长和进展.
CNPY2 影响瘤微环境,免疫功能和转移.
CNPY2显示出作为癌症检测和预后的生物标志物的潜力.

结论:

CNPY2在固体瘤进展中发挥着多方面的作用.
目前正在研究涉及CNPY2的向治疗和诊断策略.
进一步的研究是必要的,以充分了解CNPY2的致癌机制.

关键词:

血管新生的产生.生物标志物生物标志物吊顶 FGF信号调节器 2 2 免疫疗法免疫疗法瘤发生的发生因子.治疗目标是治疗的目标.瘤微环境是一个微环境.

更多相关视频

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...